Huo Xinlong, Wang Shufang
Department of Oncology, The First Hospital of Qinhuangdao City, Qinhuangdao, China.
Department of Obstetrics and Gynecology, Maternal and Child Health Care Hospital of Qinhuangdao, Qinhuangdao, China.
Front Oncol. 2021 Mar 3;11:641962. doi: 10.3389/fonc.2021.641962. eCollection 2021.
Both the International Federation of Gynecology and Obstetrics (FIGO) and the American Joint Committee on Cancer (AJCC) staging system for endometrial cancer (EC) defined the N category by the location of metastatic lymph nodes (LNs) rather than the metastatic LN count. We aimed to compare the accuracy of the AJCC staging system and the LN count-based staging system.
EC patients were selected from the Surveillance, Epidemiology and End Results (SEER) database between 2004 and 2016. Patients' characteristics were collected, including age, race, marital status, histological type, grade, therapeutic measures, the number of metastatic LNs, the number of dissected LNs, vital status, and survival in months. Overall survival (OS) was analyzed by the Kaplan-Meier (KM) method and the concordance index (C-index) was used to compare the prognostic value of the AJCC staging system and the LN count-based staging system.
We identified 4,276 EC cases from the SEER database, including 2,693 patients with stage IIIC1 and 1,583 patients with stage IIIC2. Multivariate analyses showed that independent prognostic factors for patients with stage IIIC1 included age, race, marital status, grade, histology, chemotherapy, and radiotherapy. Independent prognostic factors for patients with stage IIIC2 included age, marital status, grade, histology, chemotherapy, and radiotherapy. The C-index of the AJCC staging system and the LN count-based staging system were 0.483 and 0.617, respectively. At least six LNs should be dissected to ensure the accuracy of the LN count-based staging system.
A modified AJCC staging system based on the count of metastatic LNs might be superior to the current AJCC staging system, which still had room for improvement and further refinements were required. For accurate staging, we recommended that at least six LNs should be examined in the modified AJCC staging system.
国际妇产科联盟(FIGO)和美国癌症联合委员会(AJCC)的子宫内膜癌(EC)分期系统均根据转移性淋巴结(LN)的位置而非转移LN的数量来定义N类别。我们旨在比较AJCC分期系统和基于LN计数的分期系统的准确性。
从2004年至2016年的监测、流行病学和最终结果(SEER)数据库中选取EC患者。收集患者的特征,包括年龄、种族、婚姻状况、组织学类型、分级、治疗措施、转移性LN的数量、切除的LN数量、生命状态以及以月为单位的生存期。采用Kaplan-Meier(KM)方法分析总生存期(OS),并使用一致性指数(C指数)比较AJCC分期系统和基于LN计数的分期系统的预后价值。
我们从SEER数据库中识别出4276例EC病例,其中包括2693例IIIC1期患者和1583例IIIC2期患者。多因素分析显示,IIIC1期患者的独立预后因素包括年龄、种族、婚姻状况、分级、组织学、化疗和放疗。IIIC2期患者的独立预后因素包括年龄、婚姻状况、分级、组织学、化疗和放疗。AJCC分期系统和基于LN计数的分期系统的C指数分别为0.483和0.617。为确保基于LN计数的分期系统的准确性,应至少切除6个LN。
基于转移性LN计数的改良AJCC分期系统可能优于当前的AJCC分期系统,后者仍有改进空间,需要进一步完善。为了准确分期,我们建议在改良的AJCC分期系统中至少检查6个LN。